AlHarbi Hassan, AlAhmari Mohammed, Alanazi Abdulrahman M, Al-Ghamdi Bander, AlSuayri Abdullah, AlHaydhal Ahmed, Arafat Amr A, Algarni Khaled D, Abdelsalam Wiam, AlRajwi Sameera, AlMoghairi Abdulrahman, AlAmri Hussin, AlAhmari Saeed, AlOtaiby Mohammed
Adult Cardiology Department, Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.
Adult Cardiac Surgery Department, Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.
J Saudi Heart Assoc. 2021 Apr 19;33(1):26-34. doi: 10.37616/2212-5043.1236. eCollection 2021.
Left ventricular diastolic dysfunction (LVDD) in patients undergoing transcatheter aortic valve replacement (TAVR) is associated with poor outcomes; however, the effect of its severity is controversial. We sought to assess the impact of diastolic dysfunction on hospital outcomes and survival after TAVR and identify prognostic factors.
We included patients who underwent TAVR for severe aortic stenosis with preexisting LVDD from 2009 to 2018 (n = 325). Patients with prior mitral valve surgery (n = 4), atrial fibrillation (n = 39), missing or poor baseline diastolic dysfunction assessment (n = 36) were excluded. The primary endpoint was all-cause mortality. 246 patients were included in the study.
The median age was 80 years (25th and 75th percentiles:75-86.7), 154 (62.6%) were males and the median EuroSCORE II was 4.3 (2.2-8). Patients with severe LVDD had significantly higher EuroSCORE, and lower ejection fraction (p < 0.001). There was no difference in post-TAVR new atrial fibrillation (p = 0.912), pacemaker insertion (p = 0.528), stroke (p = 0.76), or hospital mortality (p = 0.95). Patients with severe LVDD had longer hospital stay (p = 0.036). The grade of LVDD did not affect survival (log-rank = 0.145) nor major adverse cardiovascular events (log-rank = 0.97). Predictors of mortality were; low BMI (HR: 0.95 (0.91-0.99); p = 0.019), low sodium (0.93 (0.82-2.5); p = 0.021), previous PCI (HR: 1.6 (1.022-2.66); p = 0.04), E-peak (HR: 1.01 (1.002-1.019); p = 0.014) and implantation of more than one device (HR: 3.55 (1.22-10.31); p = 0.02).
Transcatheter aortic valve replacement is feasible in patients with diastolic dysfunction, and the degree of diastolic dysfunction did not negatively affect the outcome. Long-term outcomes in those patients were affected by the preoperative clinical state and procedure-related factors.
经导管主动脉瓣置换术(TAVR)患者的左心室舒张功能障碍(LVDD)与不良预后相关;然而,其严重程度的影响存在争议。我们旨在评估舒张功能障碍对TAVR术后住院结局和生存的影响,并确定预后因素。
我们纳入了2009年至2018年因严重主动脉瓣狭窄且已存在LVDD而接受TAVR的患者(n = 325)。排除既往有二尖瓣手术史(n = 4)、心房颤动(n = 39)、基线舒张功能障碍评估缺失或不佳(n = 36)的患者。主要终点是全因死亡率。246例患者纳入研究。
中位年龄为80岁(第25和第75百分位数:75 - 86.7),154例(62.6%)为男性,中位欧洲心脏手术风险评估系统(EuroSCORE)II为4.3(2.2 - 8)。严重LVDD患者的EuroSCORE显著更高,射血分数更低(p < 0.001)。TAVR术后新发心房颤动(p = 0.912)、起搏器植入(p = 0.528)、卒中(p = 0.76)或住院死亡率(p = 0.95)无差异。严重LVDD患者的住院时间更长(p = 0.036)。LVDD分级不影响生存(对数秩检验 = 0.145),也不影响主要不良心血管事件(对数秩检验 = 0.97)。死亡率的预测因素为;低体重指数(HR:0.95(0.91 - 0.99);p = 0.019)、低钠血症(0.93(0.82 - 2.5);p = 0.021)、既往经皮冠状动脉介入治疗(PCI)(HR:1.6(1.022 - 2.66);p = 0.04)、E峰(HR:1.01(1.002 - 1.019);p = 0.014)以及植入多个装置(HR:3.55(1.22 - 10.31);p = 0.02)。
舒张功能障碍患者行TAVR是可行的,舒张功能障碍程度并未对结局产生负面影响。这些患者的长期结局受术前临床状态和手术相关因素影响。